CRISPR Has a Terrible Name – The Atlantic
The Atlantic |
CRISPR Has a Terrible Name
The Atlantic The gene-editing tool is called CRISPR, an acronym for Clustered Regularly-Interspaced Short Palindromic Repeats. More confusingly, the strands of DNA called CRISPR have been around for billions of years. Bacteria use CRISPR to slice out portions of an … CRISPR: Is It Possible to Remove Disease From DNA?WebMD Nine burning questions about CRISPR genome editing answeredPhys.Org Intellia Therapeutics Announces European Patent Office’s Decision to Grant CRISPR/Cas9 Genome Editing …GlobeNewswire (press release) Civil Eats –Genetic Literacy Project –Sports Perspectives all 13 news articles » |
Newsweek |
Spray-On Skin: ‘Miracle’ Stem Cell Treatment Heals Burns Without Scarring
Newsweek The treatment, developed by German researcher Dr. Jörg Gerlach, was the world’s first to use a patient’s stem cells to directly heal the skin. If successful, the device would mend Uram’s wounds using his body’s ability to regenerate fully functioning skin. |
Newsweek |
Spray-On Skin: ‘Miracle’ Stem Cell Treatment Heals Burns Without Scarring
Newsweek The treatment, developed by German researcher Dr. Jörg Gerlach, was the world’s first to use a patient’s stem cells to directly heal the skin. If successful, the device would mend Uram’s wounds using his body’s ability to regenerate fully functioning skin. |
Genetic Literacy Project |
CRISPR primer: A detailed look at its history and varieties
Genetic Literacy Project The most immediate thing to note is just how widespread CRISPR is as a process used by cellular life. About 40% of all studied bacteria have the system in their genome, but that’s practically nothing compared to Archaea, where 90% of all those studied … |
Genetic Literacy Project |
Video: How gene therapy could treat rare, incurable blindness
Genetic Literacy Project But now a clinical trial at four different U.S. sites, including University of Miami’s Bascom Palmer Eye Institute, is providing, quite literally, a ray of hope for those who suffer from this gene mutation. The trial will evaluate a cutting-edge … |